Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00204373
Status:
COMPLETED
Last Update Posted:
2012-10-30
First Post:
2005-09-13
Brief Title:
Treatment of Zollinger-Ellison Syndrome With Prevacid
Sponsor:
Charles Mel Wilcox MD
Organization:
University of Alabama at Birmingham
Study Overview
Official Title:
Long-Term Study of the Efficacy and Safety of Lansoprazole in the Treatment of Zollinger-Ellison and Other Acid Hypersecretors
Status:
COMPLETED
Status Verified Date:
2012-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to study the safety and efficacy of high dose Prevacid in the long-term treatment of patients who secrete abnormally large amounts of gastric acid
Detailed Description:
The aim of this protocol is to study the medical management of acid hypersecretory states including Zollinger-Ellison using Prevacid The immediate objective is to heal peptic ulcers and eliminate symptoms and in the long term to prevent relapse of symptoms lesions and complications Other objectives include observation of the efficacy in controlling gastric acid production and of the safety of high dose long-term use of Prevacid
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None